In leukemia, upregulation of p38 is linked to drug resistance against genotoxic chemotherapy,22 whereas the opposite holds true for targeted therapy; increased p38 phosphorylation is then linked to increased drug sensitivity.23 This evidence concerns the gene MAPK1 and leukemia.